Skip to main content
graph.swiss
Medtronic plc

Medtronic plc

67.58 CHF+1.89 (+2.88%)
XSWX:MDTMarket Closed
ListedCHF86.5BHealthcareMedical Devices95,000 employees

Company Profile

Legal NameMedtronic plc
CEOMr. Geoffrey Straub Martha
HeadquartersBuilding Two
Phone353 1 438 1700
Employees (FTE)95,000
SectorHealthcare
IndustryMedical Devices

Other Listings & Derivatives(1)

Business Description

Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and related services for a broad range of chronic and acute health conditions. Headquartered in Dublin, Ireland, and founded in 1949, Medtronic focuses on technologies used by hospitals, clinics, and physicians worldwide. The company operates through four main areas: its Cardiovascular Portfolio, offering products such as heart valves, stents, pacemakers, and defibrillators; its Neuroscience Portfolio, which provides spinal fixation systems, neurostimulation devices, and neurovascular products; its Medical Surgical Portfolio, supplying advanced surgical instruments, energy-based devices, and visualization tools; and its Diabetes Operating Unit, which delivers insulin pumps, continuous glucose monitoring systems, and related consumables. Medtronic plays a significant role in the healthcare sector by providing solutions that support the diagnosis, monitoring, and treatment of complex conditions, serving healthcare providers and patients across the United States, Europe, Japan, and other international markets.

Profitability & Growth

Profitability

Profit Margin+13.20%
Operating Margin+22.05%
Return on Equity (TTM)+9.84%
Return on Assets (TTM)+4.92%

Recent Year-End

Revenue29.43B
Revenue / Share28.37
Gross Profit19.22B
EBITDA10.17B
Diluted EPS2.86
Earnings Growth YoY+17.80%
Revenue Growth YoY+9.90%

Balance Sheet Snapshot

Total Cash (MRQ)

7.46B

Total Debt (MRQ)

23.59B

Current Ratio (MRQ)

2.13

Book Value / Share

31.48

Stock Statistics

Shares Outstanding1.28B
Float Shares1.28B
Avg Volume (10d)0
Avg Volume (90d)0
% Held by Insiders+0.31%
% Held by Institutions+89.60%

Valuation

Market Cap86.51B
Enterprise Value83.22B
Trailing P/E22.97
PEG Ratio1.26
Price / Sales (TTM)2.31
Price / Book (MRQ)2.09
EV / Revenue2.83
EV / EBITDA10.18

Price Summary

52-Week Low58.50
52-Week High85.22
50-Day MA63.23
200-Day MA70.17
Beta0.58

Dividends

Forward Div Rate2.32
Forward Div Yield+3.43%
Trailing Div Rate1.15
Payout Ratio+19.03%
Ex-Dividend Date2026-06-26